Alembic Q2 Gets Sartans Shot

28 Oct 2019

• By Vibha Ravi

Continuing sartans crisis, new product launches in US help Alembic post strong Q2 performance despite slowdown in other markets.

Archery — Alembic's On-Target US Strategy Aids Performance • Source: Shutterstock

More from India

More from Focus On Asia